Physician profile
Michael Babatz
NPI 1609919026
$1,933.80
in general payments reported to CMS, 2019-2025
12 companies · $244 in 2025
The $244 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $773 · 2020: $223 · 2021: $80.97 · 2022: $77.41 · 2023: $450 · 2024: $85.62 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $663 · Entertainment: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $662.93 |
| Entertainment | $116.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $391.08 | 2019-2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Coopervision INC. | $242.11 | 2019-2023 | Myday Contact Lens |
| Biotissue Holdings INC. | $207.39 | 2024-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $178.28 | 2019-2020 | |
| Johnson & Johnson Vision Care, INC. | $145.96 | 2019 | |
| Glaukos Corporation | $140.45 | 2019 | |
| Astellas Pharma US INC | $121.85 | 2025 | Izervay |
| Sun Pharmaceutical Industries INC. | $121.66 | 2023 | Cequa |
| Alcon Vision LLC | $121.50 | 2020 | |
| Sight Sciences, INC. | $108.40 | 2023 | Omni Surgical System |
| Johnson & Johnson Surgical Vision, INC. | $89.90 | 2020-2022 | |
| Optovue, INC. | $65.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Babatz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.